AR077238A1 - COMPOSITIONS FOR ORAL CARE. USE OF A POLYMER TO MANUFACTURE THE COMPOSITION - Google Patents

COMPOSITIONS FOR ORAL CARE. USE OF A POLYMER TO MANUFACTURE THE COMPOSITION

Info

Publication number
AR077238A1
AR077238A1 ARP100102264A ARP100102264A AR077238A1 AR 077238 A1 AR077238 A1 AR 077238A1 AR P100102264 A ARP100102264 A AR P100102264A AR P100102264 A ARP100102264 A AR P100102264A AR 077238 A1 AR077238 A1 AR 077238A1
Authority
AR
Argentina
Prior art keywords
polymer
composition
dye
oral care
care according
Prior art date
Application number
ARP100102264A
Other languages
Spanish (es)
Inventor
Carole Jane Philpotts
Andrew Joiner
Sheng Meng
Qingsheng Tao
Jinfang Wang
Stephen Norman Batchelor
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of AR077238A1 publication Critical patent/AR077238A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/331—Methylation site specific nuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

Reivindicacion 1: Una composicion para el cuidado bucal que comprende un polímero colorante, para modificar el color de los dientes. Reivindicacion 3: Una composicion para el cuidado bucal que comprende un polímero colorante, donde la funcionalidad del colorante está covalentemente unida al resto del polímero. Reivindicacion 5: Una composicion para el cuidado bucal de acuerdo con la reivindicacion 3 o 4, caracterizada porque el polímero colorante presenta la formula: (cadena de polímero)-(Y-colorante)x en la cual Y es un enlace entre el colorante y la cadena de polímero y x es el numero de partes de colorante asociadas a una molécula de polímero dada. Reivindicacion 6: Una composicion para el cuidado bucal de acuerdo con la reivindicacion 5, caracterizada porque Y es típicamente un grupo puente orgánico que conecta covalentemente un anillo aromático de una parte de colorante con la cadena de polímero y tiene entre 1 y 8 átomos, y el átomo se selecciona entre: C, N, O y S. Reivindicacion 7: Una composicion para el cuidado bucal de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizada porque el polímero colorante comprende partes de antraquinona. Reivindicacion 10: Una composicion para el cuidado bucal de acuerdo con cualquiera de las reivindicaciones anteriores, que comprende agua, espesante, surfactante y abrasivo.Claim 1: A composition for oral care comprising a coloring polymer, to modify the color of the teeth. Claim 3: A composition for oral care comprising a dye polymer, wherein the functionality of the dye is covalently bonded to the rest of the polymer. Claim 5: A composition for oral care according to claim 3 or 4, characterized in that the dye polymer has the formula: (polymer chain) - (Y-dye) x in which Y is a bond between the dye and The polymer chain yx is the number of dye parts associated with a given polymer molecule. Claim 6: A composition for oral care according to claim 5, characterized in that Y is typically an organic bridge group that covalently connects an aromatic ring of a dye part with the polymer chain and has between 1 and 8 atoms, and The atom is selected from: C, N, O and S. Claim 7: A composition for oral care according to any of the preceding claims, characterized in that the dye polymer comprises anthraquinone parts. Claim 10: A composition for oral care according to any of the preceding claims, comprising water, thickener, surfactant and abrasive.

ARP100102264A 2009-06-26 2010-06-25 COMPOSITIONS FOR ORAL CARE. USE OF A POLYMER TO MANUFACTURE THE COMPOSITION AR077238A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09163934 2009-06-26

Publications (1)

Publication Number Publication Date
AR077238A1 true AR077238A1 (en) 2011-08-10

Family

ID=42470871

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102264A AR077238A1 (en) 2009-06-26 2010-06-25 COMPOSITIONS FOR ORAL CARE. USE OF A POLYMER TO MANUFACTURE THE COMPOSITION

Country Status (6)

Country Link
US (2) US20120184447A1 (en)
EP (2) EP2446055A1 (en)
JP (1) JP6013910B2 (en)
AR (1) AR077238A1 (en)
ES (1) ES2669439T3 (en)
WO (1) WO2010149782A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105705653A (en) * 2013-05-10 2016-06-22 南加州大学 Dna methylation biomarkers for bladder cancer
WO2016138105A2 (en) 2015-02-24 2016-09-01 Zymo Research Corporation Assays to determine dna methylation and dna methylation markers of cancer
GB201511152D0 (en) 2015-06-24 2015-08-05 Ucl Business Plc Method of diagnosing bladder cancer
EP3625369B1 (en) 2017-05-18 2024-02-14 Genomic Health, Inc. Dna methylation and mutational analysis methods for bladder cancer surveillance
CA3112513A1 (en) * 2018-07-11 2020-01-16 Stichting Vumc Urine dna methylation markers for bladder cancer

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (en) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Method and apparatus for analyzing polynucleotide sequences
JPH09506253A (en) 1993-11-30 1997-06-24 マクギル・ユニヴァーシティ Inhibition of DNA methyltransferase
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
WO1998056952A1 (en) 1997-06-09 1998-12-17 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (en) 1997-11-27 1999-07-01 Epigenomics Gmbh Process for making complex DNA methylation fingerprints
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
WO2001092538A1 (en) * 2000-06-01 2001-12-06 Otsuka Pharmaceutical Factory, Inc. Method of detecting and quantifying human p450 molecular species and probe and kit for this method
DE50113454D1 (en) * 2000-09-01 2008-02-14 Epigenomics Ag METHOD OF DETERMINING THE METHYLATION GRADE OF CYTOSINS IN GENOMIC DNA IN THE SEQUENCE CONTEXT 5'-CPG-3 '
AU2002212187A1 (en) * 2000-09-01 2002-03-13 Epigenomics Ag Diagnosis of illnesses or predisposition to certain illnesses
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
USH2220H1 (en) * 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
US20040265833A1 (en) * 2003-06-23 2004-12-30 Cathy Lofton-Day Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
US8367336B2 (en) * 2004-06-01 2013-02-05 University Of Southern California Association of the DNA methylation profile of the CYP1B1 gene with response to adjuvant therapy in breast cancer
US20080003609A1 (en) * 2006-05-10 2008-01-03 The Cleveland Clinic Foundation Method of detecting bladder urothelial carcinoma
EP2258871B1 (en) * 2007-01-19 2014-05-14 Epigenomics AG Methods and nucleic acids for analyses of cell proliferative disorders
CN101353695B (en) * 2007-07-23 2013-05-01 上海市肿瘤研究所 Method and reagent kit for analyzing and diagnosing bladder cancer by means of uropsammus DNA methylation profile
US9322065B2 (en) * 2007-09-17 2016-04-26 Mdxhealth Sa Methods for determining methylation of the TWIST1 gene for bladder cancer detection
WO2009069984A2 (en) * 2007-11-30 2009-06-04 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene

Also Published As

Publication number Publication date
JP2012530508A (en) 2012-12-06
ES2669439T3 (en) 2018-05-25
US20150152509A1 (en) 2015-06-04
JP6013910B2 (en) 2016-10-25
EP2966181A1 (en) 2016-01-13
US20120184447A1 (en) 2012-07-19
WO2010149782A1 (en) 2010-12-29
EP2446055A1 (en) 2012-05-02
EP2966181B1 (en) 2018-02-14

Similar Documents

Publication Publication Date Title
CO6290631A2 (en) ORAL COMPOSITION CONTAINING AMINO ACIDS AND A WHITENING AGENT
AR077238A1 (en) COMPOSITIONS FOR ORAL CARE. USE OF A POLYMER TO MANUFACTURE THE COMPOSITION
AR080814A1 (en) COMPOSITION FOR ORAL CARE
BR112012015171A2 (en) "kit containing photosensitizing dyes".
AR080507A1 (en) COMPOSITIONS OF LIQUID DETERGENTS THAT INCLUDE A DIAMID GELIFIER AND PROCESSES TO PREPARE THEM
BRPI0910081A2 (en) HUMAN KERATIN FIBER CLARING PROCESS, HUMAN KERATIN FIBER COLORING PROCESS AND DEVICES WITH VARIOUS COMPARTMENTS
CL2012000716A1 (en) Non-therapeutic method for disinfecting a surface comprising i) applying a composition comprising eugenol, terpineol, thymol and a carrier, and ii) rinsing it with a suitable solvent; antimicrobial composition; and non-therapeutic use of the composition for improved hand, oral and hard surface hygiene.
GT200500119A (en) DERIVATIVES OF TETRAAZABENZO [E] AZULENO AND ITS ANALOGS
BRPI1015283A8 (en) COMPOSITIONS FOR KERATIN DYEING INCLUDING A RADICAL ELIMINATOR AND USE THEREOF.
ECSP088221A (en) ALFA2C ADRENORECEPTORS AGONISTS
AR067316A1 (en) OXYGEN SEQUESTING MOLECULES, ITEMS CONTAINING THEM AND METHODS FOR USE
MY149525A (en) Triphenodioxazine dyes
PA8768301A1 (en) NEW TRICYCLIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
GT200400146A (en) SUBSTITUTED DERIVATIVES OF TIAZOL-BENZOISOTIAZOL DIOXIDE, PROCEDURE FOR PREPARATION AND USE
UY31712A1 (en) NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR20110062A (en) NEW DERIVATIVES OF ACILAMINOBENZAMIDA
CL2018000005A1 (en) Composition for oral care comprising calcium silicate.
GT200300108A (en) BENZOXAZINE DERIVATIVES AND USES OF THE SAME
NO20073026L (en) 2-Alkoxy-3,4,5-trihydroxyalkylamides, preparation and compositions thereof, and use thereof
ES2721400T3 (en) Diclofenac composition
ECSP088603A (en) NEW N- (FLUOR-PIRAZINIL) -PENYLSULPHONAMIDES AS MODULATORS OF THE CCR4 CHEMIOQUINE RECEPTOR
GT200600130A (en) TETRAHYDROPIRIDOAZEPIN-8-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
CO6341629A2 (en) DERIVATIVES OF BENZOTIOFENO ALKANOL PIPERAZINA AND ITS USE AS ANTIDEPRESSANTS
CR11449A (en) GSM INTERMEDIATE PRODUCTS
PA8658201A1 (en) INJECTABLE OR ADMINISTRABLE FORMULATIONS BY ORAL ROUTE OF DERIVATIVES OF AZETIDINA

Legal Events

Date Code Title Description
FG Grant, registration